No Controversy Here
While controversy exists in the USA concerning research with embryonic stem cells, everyone agrees that using adult stem cells are appropriate and efficacious. Rabin Medical Center has made a major breakthrough in applying adult stem cells to treat Parkinson's disease by developing NurOwn, a technology that generates neuron-like cells derived from human bone marrow. Using the patient's own bone marrow to supply dopamineproducing cells circumvents problems of immunity and compatibility. Credit for the discovery goes to Prof. Eldad Melamed, Director of Neurology at the Rabin Medical Center and member of the Michael J. Fox Foundation for Parkinson's Research, together with Dr. Daniel Offen, Director of Laboratory of Neurosciences at Rabin Medical Center, and Dr. Yosef Levy. Commercialized by Brainstorm Cell Therapeutics based in Tel Aviv, NurOwn actually produces the missing chemical that enables restoration of motor movement.
Related Articles
The Earlier the Better: Probing Malignancies in Newborns
Building on their established international partnership, GE
Healthcare and Rabin Medical Center are developing innovative
products and working on creative medical solutions to facilitate
the early diagnosis of medical problems in pregnant women
and their fetuses.
Japanese Healing Art Enhances Birthing Process
The Schneider Women's Hospital at RMC strives to provide new and modern techniques to enhance the birthing process, and has now introduced the use of shiatsu techniques.
Pain and the Relation to Treatment with Cannabis
50-80% of people with Parkinson's disease suffer from a specific type of pain, which until today has not been diagnosed and treated as a general part of this disease.